Article
New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells.
Blood - 1 Oct 2007
Pérez-Persona Ernesto, Vidriales María-Belén, Mateo Gema, García-Sanz Ramón, Mateos Maria-Victoria, de Coca Alfonso García, Galende Josefina, Martín-Nuñez Guillermo, Alonso José M, de Las Heras Natalia, Hernández José M, Martín Alejandro, López-Berges Consuelo, Orfao Alberto, San Miguel Jesús F
Abstract excerpt
Monoclonal gammopathy of uncertain significance (MGUS) and smoldering multiple myeloma (SMM) are plasma cell disorders with a risk of progression of approximately 1% and 10% per year, respectively. We have previously shown that the proportion of bone marrow (BM) aberrant plasma cells (aPCs) within the BMPC compartment (aPC/BMPC) as assessed by flow cytometry (FC) contributes to differential diagnosis between MGUS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
